MedElevator
Войти в исследования Annals of plastic surgery · 2014
Comparison of outcomes using AlloDerm versus FlexHD for implant-based breast reconstruction.
Сравнительное исследованиеОценочное исследованиеСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Daniel Z, Mathes David W, Neligan Peter C, Said Hakim K, Louie Otway
Аннотация
BACKGROUND: Prosthetic reconstruction using human acellular dermis (ADM) is a common practice in breast reconstruction. AlloDerm and FlexHD are two different forms of ADM, each with unique characteristics. No studies have directly compared the postoperative complications of these 2 products.
METHODS: The outcomes of 547 consecutive implant-based breast reconstructions were reviewed.
RESULTS: Reconstruction was performed in 382 consecutive women (547 total breasts), employing mostly immediate reconstruction (81%). Mean follow-up was 6.4 months. Among immediate reconstructions, 165 used AlloDerm and 97 used FlexHD. Complications were similar by univariate analysis. In multivariate analysis, smoking and higher initial implant fill were risk factors for delayed healing. The use of FlexHD, single-stage reconstruction, and smoking were independent risk factors for implant loss.
CONCLUSIONS: There is no significant difference in the complication rates between AlloDerm and FlexHD in immediate breast reconstruction. Multivariate analysis suggests that FlexHD may be a risk factor for implant loss.
METHODS: The outcomes of 547 consecutive implant-based breast reconstructions were reviewed.
RESULTS: Reconstruction was performed in 382 consecutive women (547 total breasts), employing mostly immediate reconstruction (81%). Mean follow-up was 6.4 months. Among immediate reconstructions, 165 used AlloDerm and 97 used FlexHD. Complications were similar by univariate analysis. In multivariate analysis, smoking and higher initial implant fill were risk factors for delayed healing. The use of FlexHD, single-stage reconstruction, and smoking were independent risk factors for implant loss.
CONCLUSIONS: There is no significant difference in the complication rates between AlloDerm and FlexHD in immediate breast reconstruction. Multivariate analysis suggests that FlexHD may be a risk factor for implant loss.
Предметные рубрики MeSH
Acellular DermisBreast ImplantationBreast ImplantsCellulitisCollagenComorbidityDiabetes MellitusEquipment Failure AnalysisFemaleFollow-Up StudiesHumansIncidenceMammaplastyMastectomyMiddle AgedMultivariate AnalysisObesityProsthesis FailureRetrospective StudiesRisk FactorsSkin TransplantationSmokingSurgical Wound InfectionTissue ExpansionTissue Expansion DevicesTreatment OutcomeWound Healing